CurrentAetnaPolicy 0508

Cataract Surgery

Clinical policy governing medical necessity, coverage, and coding for cataract surgery, pre-operative testing, intraocular lenses, and related procedures for Aetna members.

Policy Summary

PayerAetna

PolicyCataract Surgery

Policy CodePolicy 0508

Change TypeNo material change

Effective DateJun 12, 2001

Next Review DateMay 23, 2024

Key ActionDocument best-corrected visual acuity, exam confirming cataract as limiting factor, and informed consent when charging patient for premium services.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

20/50VA threshold (routine)

20/40VA threshold (additional criteria)

6 moNd:YAG earliest interval

ListNon-covered IOLs

multipleCode groups

0.75%-0.97%CTR frequency (reported)

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage Criteria

Initial cataract surgery medical necessity

Covered when ALL of the following are met for members with visual disability:

Standard 20/50 criteria

Subjective: Member perceives impaired ability to carry out needed or desired activities (e.g., driving, reading, occupational tasks); decision based on personal assessment of visual disability and lifestyle impact
Includes near vision concerns and impact on driving/work
Objective: Best correctable Snellen visual acuity in the affected eye is 20/50 or worse; eye exam confirms cataract is the limiting factor and other factors do not preclude improvement; member medically/mentally fit for surgery20/50
Educational: Member has been educated about risks, benefits, alternatives and determines expected benefit outweighs risks, cost and inconvenience

20/40 (better) with additional criteria

Subjective: Member perceives impairment; includes complaints of disabling glare in bright ambient light inconsistent with dark-room acuity
Requires documentation of loss of vision in bright light
Objective: Either significant loss of visual acuity in bright ambient light confirmed by glare testing/BAT/contrast sensitivity OR monocular diplopia/polyopia OR inter-eye visual disparity (anisometropia)
Eye exam must confirm cataract is limiting factor and surgery is safe
Educational/Health: Member educated about risks/benefits and medically/mentally fit for surgery

Other medically necessary indications regardless of acuity: Lens-induced disease (e.g., phacomorphic/phacolytic glaucoma), need to visualize the fundus to manage other ocular disease (e.g., diabetic retinopathy requiring photocoagulation), preparation for vitrectomy or retinal repair, or other intraocular pathology requiring clear media

Includes cases of zonulysis, pseudo-exfoliation, ectopia lentis and indication for capsular tension ring when integral to surgery (CTR not separately reimbursed)

Nd:YAG capsulotomy

Covered when ALL of the following are met:

Nd:YAG capsulotomy: Performed 6 months or more following cataract extraction for visually significant posterior capsule opacification causing decreased vision>= 6 months

Requests within 6 months should be forwarded for medical review; prophylactic or concurrent Nd:YAG at time of cataract surgery is considered investigational

Experimental and Investigational

Considered experimental/investigational (not covered) due to insufficient evidence:

Experimental IOLs and procedures: Piggyback posterior chamber IOLs; Nd:YAG laser capsulotomy performed concurrently with or prophylactically at the time of cataract surgery; placement of Nd:YAG routinely without clinically significant posterior capsule opacification

Specified specialized pre-operative tests (corneal pachymetry, corneal topography, electrophysiologic tests including ERG, external ocular photography, fluorescein angiography, formal visual fields, specialized color vision tests, specular microscopy, contact/immersion B-scan, visual evoked potentials) are considered experimental/investigational for routine pre-operative evaluation when cataract is the sole indication

Standard cataract surgery and standard IOLs

Covered when meeting standard surgical and clinical indications for cataract removal and IOL implantation:

Standard cataract surgery coverage: Cataract removal with implantation of standard monofocal IOLs is covered when clinical history and examination indicate visual impairment due to cataract and appropriate pre-operative assessment is performed

Standard monofocal IOLs are considered standard; supported by Panel and AAO guidance

Premium and refractive IOLs

Coverage and medical necessity determinations for non-standard IOLs:

Premium/multifocal/accommodating IOLs: Multifocal, accommodating, toric, extended depth of focus, trifocal, light‑adjustable and other new-technology IOLs intended to reduce dependence on glasses or contact lenses are considered not medically necessary for the refractive/presbyopia-correcting function; cataract surgery may be covered but the premium lens itself is non‑covered

Refractive IOLs or IOLs implanted solely for refractive purposes are excluded if refractive surgery is excluded by contract; CMS ruling treats presbyopia‑correcting function as non-covered benefit

Adjunctive devices (CTR) and YAG capsulotomy

Adjuncts and post-operative procedures:

Capsular tension rings: CTR implantation may be considered when zonular weakness, lens subluxation, or intraoperative capsular instability is present to stabilize the capsular bag and improve IOL centration/rotational stability

CTR is integral to the surgical procedure and not separately reimbursed; evidence shows low implantation rates (about 0.75–0.97%) and RCT data support improved toric IOL rotational stability when CTR is co‑implanted

Nd:YAG capsulotomy (post-op): Nd:YAG laser capsulotomy is indicated when posterior capsule opacification develops and causes visual impairment; it should not be performed prophylactically or scheduled routinely at the time of cataract surgery

Panel found PCO is uncommon within first 6 months and advised against routine or prophylactic capsulotomy

Evidence summaries relevant to coverage decisions

Key evidence summaries and comparative outcomes

Accommodative vs Monofocal IOL outcomes: Meta-analyses and RCTs show no clear, consistent improvement in near visual acuity with accommodating IOLs compared to monofocal IOLs; small short-term gains reported in some trials but heterogeneity and uncertain long-term distance acuity; higher rates of posterior capsular opacification and subsequent capsulotomy have been reportedevidence quality varies (low–moderate)

See randomized trials and meta-analyses (e.g., Takakura et al, Cochrane evidence)

Multifocal IOL outcomes: Multifocal IOLs can improve near vision relative to monofocal lenses but may reduce contrast sensitivity and increase photic phenomena (glare/haloes); trade-offs should be discussed and patient willingness for spectacle independence is keyeffect size varies

Prospective randomized trials report increased dysphotopsia and variable contrast sensitivity

IOL material and PCO risks:

Cataract removal is considered not medically necessary when the member achieves satisfactory functional vision with glasses or other visual aids, when the member’s lifestyle is not compromised by the cataract, or when the member is medically unfit and surgery will not improve independence (for example, comatose patients, end-stage dementia, or no light perception). Providers should document that conservative measures were tried or remain satisfactory before electing surgery.

Intraocular lens (IOL) implants performed solely for refractive purposes, or implanted in conjunction with refractive procedures (e.g., LASIK), are excluded when those refractive procedures are not covered by the member’s contract. Multifocal, accommodating, and other refractive IOLs whose intent is to obviate the need for glasses are treated as non-covered new-technology items even though the cataract surgery itself may be medically necessary if standard criteria are met.

The policy explicitly lists certain HCPCS codes as not covered for the indications in this bulletin: Q1004, Q1005, V2702, V2755, V2787, V2788. Use of these codes for the non-covered functions described in this CPB may be denied.

A 2005 CMS determination concluded that the presbyopia-correcting function of an IOL is equivalent to providing refractive correction (similar to eyeglasses) and is not a covered benefit. Consequently, additional provider services or charges associated specifically with inserting or monitoring a presbyopia-correcting IOL (for example, postoperative refractive exams tied solely to the presbyopia-correcting function) are not a covered benefit and should not be submitted for coverage as a distinct reimbursable service.

A Cochrane review found no randomized or quasi-randomized trials comparing cataract removal versus no surgery for cataracts that developed after vitrectomy. This represents an evidence gap rather than a prescriptive exclusion; clinical decisions for post‑vitrectomy cataract should be individualized and documented due to the lack of RCT evidence.

Clinical Policy Bulletins are developed to assist in administering plan benefits and provide a partial, general description of those benefits. They do not constitute a contract or guarantee of coverage or outcomes. Treating providers remain responsible for medical advice and treatment; the bulletin may be updated and coverage determinations are subject to change.

Aetna considers the following new-technology IOL types as non-covered deluxe or not medically necessary when intended to reduce dependence on glasses: multifocal, accommodating, toric, extended depth-of-focus (EDOF), trifocal, and light-adjustable IOLs. When these lenses are elected by the member, the cataract removal may be covered if standard criteria are met but the premium/new-technology lens itself is non-covered.

Multifocal and accommodating IOLs are considered not medically necessary when the primary intent is to eliminate the need for reading glasses or contact lenses after surgery. If a member elects these lenses, the device is treated as a non-covered item and should be billed accordingly; the underlying cataract surgery remains subject to standard medical necessity criteria.

The policy reiterates the CMS determination that the presbyopia-correcting function of certain IOLs is not a covered benefit. Providers should therefore recognize that services and supplies billed specifically for the presbyopia-correcting aspect of an IOL (and related postoperative services provided solely for that purpose) are not eligible for coverage under this policy.

Femtosecond laser-assisted cataract surgery (FLACS) has not been demonstrated to be cost-effective versus conventional phacoemulsification at current additional costs in published cost-effectiveness analyses. Routine use of FLACS for all patients is not supported on a cost-effectiveness basis; if FLACS or other premium services are offered, additional patient charges are permissible only after prior discussion and documented informed consent.

Coding

Covered CPT Codes (if selection criteria met)CPTCovered

66820	Discission of secondary membranous cataract (opacified posterior lens capsule and/or anterior hyaloid); stab incision technique
66821	Laser surgery (e.g., YAG laser) (one or more stages)
66830-66986	Removal of cataract
76511	Ophthalmic ultrasound, diagnostic; quantitative A-scan only
76516	Ophthalmic biometry by ultrasound echography, A-scan
76519	With intraocular lens power calculation
92136	Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation
92002-92004	Ophthalmologic services: new patient
92012-92014	Ophthalmologic services: established patient

CPT Codes not covered for indications listedCPTNot Covered

0333T	Visual evoked potential, screening of visual acuity, automated
0509T	Electroretinography (ERG) with interpretation and report, pattern (PERG)
76514	Ophthalmic ultrasound, diagnostic; corneal pachymetry
92025	Computerized corneal topography
92081-92083	Visual field examination

HCPCS codes covered if selection criteria are metHCPCSCovered

C1780	Lens, intraocular (new technology) [standard fixed monofocal posterior chamber intraocular lenses (IOL) for aphakia only]
V2630	Anterior chamber intraocular lens
V2631	Iris supported intraocular lens
V2632	Posterior chamber intraocular lens

HCPCS codes not covered for indications listedHCPCSNot Covered

Q1004	New technology intraocular lens category 4 as defined in Federal Register notice
Q1005	New technology intraocular lens category 5 as defined in Federal Register notice
V2702	Deluxe lens feature
V2755	U-V lens, per lens
V2787	Astigmatism correcting function of intraocular lens
V2788	Presbyopia correcting function of intraocular lens

ICD-10 codes covered if selection criteria are metICD-10Covered

E08.36,E09.36,E10.36,E11.36,E13.36	Diabetes mellitus with diabetic cataract
H25.011-H26.9	Cataract
H27.00-H27.03	Aphakia
H52.31-H52.32	Anisometropia and aniseikonia

B-scan Ultrasound CPT covered if selection criteria metCPTCovered

76512

B-scan (with or without superimposed non-quantitative A-scan)

Covered HCPCS (if selection criteria met)HCPCSCovered

C1780	Lens, intraocular (new technology) [standard fixed monofocal posterior chamber intraocular lenses (IOL) for aphakia only]
V2630	Anterior chamber intraocular lens
V2631	Iris supported intraocular lens
V2632	Posterior chamber intraocular lens

HCPCS codes not covered for indications listedHCPCSNot Covered

Q1004	New technology intraocular lens category 4 as defined in Federal Register notice
Q1005	New technology intraocular lens category 5 as defined in Federal Register notice
V2702	Deluxe lens feature
V2755	U-V lens, per lens
V2787	Astigmatism correcting function of intraocular lens
V2788	Presbyopia correcting function of intraocular lens

Other related HCPCSHCPCS

V2797

Vision supply, accessory, and/or service component of another HCPCS vision code

B-scan ultrasound CPTCPTCovered

76512

B-scan (with or without superimposed non-quantitative A-scan)

ICD-10 codes covered if selection criteria are met (examples)ICD-10Covered

E08.36	Diabetes mellitus with diabetic cataract
E09.36	Diabetes mellitus with diabetic cataract
E10.36	Diabetes mellitus with diabetic cataract
E11.36	Diabetes mellitus with diabetic cataract
E13.36	Diabetes mellitus with diabetic cataract
H25.011	Cataract
H26.9	Cataract
H27.00	Aphakia
H27.03	Aphakia

ICD-10 listed as not covered for some indicationsICD-10Not Covered

H25.011

Age-related cataract (listed among ICD-10 not covered for indications in CPB section)

Visual acuity thresholds — cataract surgery eligibility

Standard visual acuity thresholdBest-correctable Snellen visual acuity 20/50 or worse in the affected eye

Higher-acuity pathwayBest-correctable Snellen visual acuity 20/40 or better — eligible only when additional functional criteria are met (e.g., disabling glare confirmed in bright ambient light, documented significant loss of acuity in bright light by glare/BAT/contrast testing, monocular diplopia/polyopia, or anisometropia)

Documentation requirement for 20/40 casesQuantitative testing (e.g., glare testing, brightness acuity testing, contrast sensitivity) required to confirm complaints when acuity is 20/40 or better

Provider Actions and Billing Guidance

Prior Authorization

Prior Authorization and Code-Based Selection

Prior authorization may be required for certain cataract-related procedures and services. Verify payer-specific prior authorization rules for cataract surgery, femtosecond laser-assisted procedures, new-technology IOLs, or adjunctive services before scheduling to avoid claim denials.

Check payer prior authorization policies for listed CPT/HCPCS codes and for premium IOLs or FLACS-related ancillary services.

Billing Rule

Code-Based Coverage Requires Selection Criteria

Coverage of specific CPT/HCPCS codes is conditional on meeting the policy's clinical selection criteria. Codes listed as “covered if selection criteria are met” require documentation demonstrating that medical necessity criteria are fulfilled.

Verify that submitted CPT/HCPCS codes correspond to documented criteria (e.g., visual acuity thresholds, glare testing results, functional impairment).

Background

Cataract removal with implantation of an intraocular lens is guided by the member’s functional impairment and by objective measures of vision. Standard coverage is generally based on best-corrected Snellen visual acuity thresholds (for example, 20/50 or worse, or 20/40 with documented functional impairment or glare testing). Pre-operative biometry (A‑scan or optical coherence interferometry) is used to calculate IOL power, and diagnostic B‑scan ultrasound is appropriate when dense media prevent posterior-segment visualization (for example, Morgagnian or total cataract). Providers should document subjective impairment, exam findings that cataract is the limiting factor, and that the member was informed of risks, benefits, and alternatives.

Definitions

B‑scan ultrasound — definition and indications

DefinitionB‑scan ultrasound: diagnostic ultrasonography used when direct visualization of the posterior segment is difficult or impossible (e.g., dense cataract, corneal opacities, hyphema, lid problems)

IndicationsMedically necessary for pre-operative posterior segment evaluation when the fundus cannot be visualized (e.g., Morgagnian cataract) or to rule out retinal detachment or vitreous hemorrhage

Billing noteB‑scan is billed separately and used in place of A-scan when visualization is limited

A-scan / Optical biometry — definition and role

DefinitionA-scan/Optical biometry: A-mode ultrasound or optical coherence biometry used pre-operatively to determine intraocular lens (IOL) pseudophakic power

Medical necessity

Revision History

2001-06-12effective

Policy became effective.

2023-08-01last_reviewLatest

Policy underwent routine review (last review date recorded).

2024-05-23next_review

Next scheduled policy review date.

Policy Summary

PayerAetna

PolicyCataract Surgery

Policy CodePolicy 0508

Change TypeNo material change

Effective DateJun 12, 2001

Next Review DateMay 23, 2024

Key ActionDocument best-corrected visual acuity, exam confirming cataract as limiting factor, and informed consent when charging patient for premium services.

SourceLink

On This Page

Observational and trial data suggest differences in posterior capsular opacification by lens material (e.g., higher PCO with some hydrophilic acrylics) and heterogeneity across trials prevents a single recommendation for optimal material

observational/heterogeneous trial data

Some trials in uveitic eyes show similar visual improvement across materials but mixed complication profiles

Pre-operative testing: RCT evidence indicates routine pre-operative medical testing does not reduce intra- or post-operative medical adverse events compared to selective testing; specialized pre-op tests listed have no proven value for routine evaluationlarge RCTs/ systematic reviews

Selective use of B‑scan ultrasound is medically necessary when posterior segment cannot be visualized

Corneal astigmatism threshold for toric IOL trials

Corneal astigmatism threshold>= 1.5 D (used as inclusion criterion in the randomized toric IOL + CTR rotational stability trial)

Study contextTrial enrolled eyes with regular corneal astigmatism >= 1.5 D undergoing toric IOL implantation with or without CTR

Related exclusion noted in trialEyes with corneal pathology were excluded from the study

Specular endothelial cell count exclusion in toric IOL trial

Specular endothelial cell count exclusionEyes with specular endothelial cell count < 2,000/mm2 were excluded from the toric IOL trial

Trial implicationLow endothelial cell count considered a contraindication for inclusion in the reported trial evaluating toric IOL ± CTR

Clinical relevanceConfirm endothelial cell status before elective toric IOL procedures in eyes at risk

A-scan/B-scan and biometry codes (e.g., 76511, 76516, 92136) are billed separately when used and must be justified.

Denial Risk

Non-Coverage of Presbyopia-Correcting / Premium IOL Functionality

Presbyopia-correcting, multifocal, accommodating, and other “premium” IOLs are considered not medically necessary when the intent is to reduce dependence on glasses; the lens implant itself is non-covered even if cataract surgery meets medical necessity. Any physician or device services solely attributable to the presbyopia-correcting function are also non-covered.

HCPCS V2788 (presbyopia-correcting function) and related premium IOL codes (Q1004, Q1005, V2787, etc.) are listed as not covered for indications in this CPB.
When cataract extraction meets criteria, standard monofocal IOL implantation is covered; new-technology IOL devices remain non-covered.

Documentation Required

Patient Consent and Billing for Additional Services

If a patient will be charged extra for premium services (e.g., premium IOLs, FLACS incremental services), the provider must discuss additional out-of-pocket costs in advance and obtain documented informed consent. Extra charges may be billed to the patient only for services that are truly additional to the covered procedure.

Document prior discussion and signed informed consent for any extra charges.
Ensure the billed incremental service is distinct from the covered surgery (per ASCRS/ASOA guidance).

Documentation Required

Documentation Availability and Risk

Maintain documentation supporting medical necessity and coding decisions; these records must be available upon request. Failure to provide required documentation may lead to claim denial or retrospective payment recovery.

Required documentation includes: best-corrected Snellen acuity, glare/contrast testing results when applicable, symptom narrative, slit-lamp exam findings, and rationale that cataract is the limiting factor.
Retain operative notes, pre-operative assessments, and informed-consent forms for audit.

Denial Risk

Experimental / Investigational Procedures — Denial Risk

Certain procedures and technologies are considered experimental/investigational and may be denied as not covered. Providers should not expect payment for procedures designated as experimental unless explicit coverage criteria are present.

Examples listed as experimental/investigational: piggyback posterior chamber IOLs; Nd:YAG capsulotomy when performed concurrently, prophylactically, or routinely without clinically significant posterior capsule opacification.
Specialized pre-operative services without separate indication (e.g., routine electrophysiologic tests, corneal pachymetry, external photography) are considered of no proven routine value and may be non-covered when used solely for cataract work-up.

Billing Rule

Not-Covered HCPCS / CPT Features

Specific HCPCS/CPT codes are identified as not covered for indications in this Clinical Policy Bulletin. Confirm that any HCPCS or CPT code billed is allowable under the member’s benefits and the CPB definitions before submission.

Not-covered HCPCS examples: Q1004, Q1005, V2702, V2755, V2787, V2788.
Not-covered CPT/other codes for listed indications include 0333T, 0509T, 76514, 92025, 92081–92083, and procedures related to Optiwave Refractive Analysis (ORA).

Note

Pre-Operative Testing and B-Scan Considerations

Pre-operative evaluation should include a comprehensive ophthalmologic exam and, when indicated, diagnostic biometry (A-scan or optical coherence biometry). B-scan ultrasonography is appropriate when dense cataract or other factors prevent posterior segment visualization.

A-scan (76511/76516 with/without IOL power calculation) is used for IOL power determination and billed separately when performed.
B-scan is indicated for dense/mature cataracts or when the posterior segment cannot be visualized (e.g., Morgagnian cataract) to rule out retinal detachment or vitreous hemorrhage.

Documentation Required

Consent, Clinical Rationale, and Inpatient Justification

Document the clinical rationale and informed consent when performing additional or non-routine pre-operative tests, when inpatient cataract surgery is performed, or when charging for premium services. Inpatient cataract surgery requires documentation justifying why outpatient care is not appropriate.

Inpatient setting may be medically necessary only with documented reasons such as need for prolonged skilled nursing care, multiple complex ocular procedures, severe comorbidities, or functional/incapacitating mental/physical disability.
Record the clinical indications that make inpatient care or additional testing necessary and include in the medical record.

Note

Provider Responsibility and Policy Disclaimer

Providers are responsible for medical advice and for maintaining current knowledge of policy updates. Clinical Policy Bulletins are tools to assist benefit administration but do not constitute offers of coverage or replace the treating provider’s clinical judgment.

Treating providers remain responsible for patient care decisions.
CPBs are subject to change; verify current policy language and member benefit terms when making coverage determinations.

Note

Consideration of FLACS vs Conventional Phaco

When choosing surgical technique, consider that femtosecond laser-assisted cataract surgery (FLACS) has not consistently demonstrated cost-effectiveness or superior overall risk profile compared with conventional phacoemulsification for routine cases. Use conventional phacoemulsification for routine cataract cases unless specific clinical circumstances justify FLACS and the patient has provided informed financial consent for any additional services.

Document the clinical justification for FLACS and evidence of prior discussion of extra patient costs if any incremental services are billed.
FLACS may be permissible when used with premium IOLs only after appropriate consent and when charges are for distinct additional services.

Considered medically necessary as part of routine pre-operative work-up to calculate IOL power; optical coherence biometry may be used in place of A- or B-scan

CodingCPT codes for A-scan and partial coherence interferometry (e.g., 76511, 76516, 92136) listed as covered if selection criteria are met

Intraocular lens (IOL) — definition and types

DefinitionIntraocular lens (IOL): a permanent plastic lens implanted inside the eye to replace the crystalline lens removed during cataract surgery

Common typesMonofocal (standard), multifocal, accommodating, toric, and phakic; premium/refractive IOLs aim to reduce spectacle dependence

Coverage stanceStandard monofocal IOLs are covered when cataract surgery criteria are met; multifocal/accommodative/other premium IOLs are considered non-covered/new technology for presbyopia-correcting intent

Capsular tension ring (CTR) — definition and indications

DefinitionCapsular tension ring (CTR): an endo-capsular flexible ring implanted to stabilize the lens capsule in eyes with zonular weakness or subluxation

IndicationUsed for zonular instability, lens subluxation, or intraoperative capsular instability to reduce complications and improve IOL centration/rotational stability

Implantation frequencyReported implantation rates in cited series are low (CTR utilized in selected complicated cases rather than routine implantation)

Accommodative IOL — definition and trial examples

DefinitionAccommodative IOL: an intra‑ocular lens designed to restore some accommodation (near focus) after cataract surgery

Examples used in trialsHumanOptics 1CU and AT-45 (Crystalens) were commonly evaluated in randomized trials and meta-analyses

Evidence summaryMeta-analyses and RCTs report no clear consistent near-vision benefit over monofocal lenses and possible increased PCO/capsulotomy rates

Multifocal IOL — definition and visual considerations

DefinitionMultifocal IOL: an intra‑ocular lens with multiple optical zones intended to provide useful vision at near and distance

Potential adverse effectsAssociated with possible visual disturbances such as glare, haloes, dysphotopsia, and reduced contrast sensitivity

Clinical noteMultifocal IOLs often improve near vision relative to monofocal IOLs but may involve optical compromises that affect patient selection and satisfaction

Posterior capsular opacification (PCO) — definition and treatment

DefinitionPosterior capsular opacification (PCO): late opacification of the posterior capsule after IOL implantation that can reduce visual acuity

Typical treatmentTreated with Nd:YAG laser posterior capsulotomy when visually significant

Outcome notePCO incidence and timing may vary by IOL material; some studies report higher PCO rates with hydrophilic acrylic lenses

Multifocal IOL — design and clinical trade-offs

Design intentMultifocal IOLs are designed with multiple optical zones to provide vision at a range of distances and reduce the need for reading glasses

Trade-offsPotential for reduced contrast sensitivity and increased photic phenomena compared with monofocal IOLs

Patient selectionPatient motivation for spectacle independence and counseling about potential visual disturbances are key to decision-making

FLACS — definition and intended benefits

DefinitionFemtosecond Laser-Assisted Cataract Surgery (FLACS): use of a femtosecond laser to perform steps such as capsulotomy, lens fragmentation, and corneal incisions prior to phacoemulsification

Intended benefitsAims to increase capsulotomy circularity/centration and reduce phacoemulsification energy (effective phaco time)

Coverage/consent noteFLACS may be an equally effective alternative but is not clearly cost‑effective; additional patient billing for extra services (e.g., premium IOL) requires prior discussion and consent

Optiwave Refractive Analysis (ORA) System — definition

DefinitionOptiwave Refractive Analysis (ORA) System: an intra‑operative wavefront aberrometer used during refractive cataract surgery to measure aphakic refractive error and assist IOL power calculations

Intended useCaptures intra-operative wavefront images to calculate total refractive error (phakic/aphakic/pseudophakic) and aid IOL power selection in complex eyes

Policy stanceORA is listed in the document as not medically necessary for routine cataract surgery

Femtosecond Laser-Assisted Cataract Surgery (FLACS) — technique and purpose

Technique descriptionFemtosecond laser-assisted cataract surgery uses a femtosecond laser to perform capsulotomy, lens fragmentation, and corneal incisions before completing removal by phacoemulsification

PurposeIntended to increase precision of capsulotomy and reduce ultrasound energy required during phacoemulsification

Clinical considerationsLearning curve present; safety and cost-effectiveness not definitively superior to conventional phacoemulsification

Intra‑cameral (IC) antibiotics — definition and examples

DefinitionIntra-cameral (IC) antibiotics: antibiotics (e.g., cefuroxime, moxifloxacin) injected into the anterior chamber at the time of cataract surgery to reduce the risk of acute postoperative endophthalmitis

ExamplesCefuroxime and moxifloxacin cited as commonly used agents in large observational studies and meta-analyses

EvidenceLarge studies and meta-analyses report reductions in postoperative endophthalmitis with IC antibiotics

Anisometropia — definition and relevance

DefinitionAnisometropia: visual disparity existing between the two eyes

Relevance to eligibilityInter-eye visual disparity (anisometropia) is listed as an objective indication that can support cataract surgery when acuity is 20/40 or better

AssessmentDocument anisometropia in the eye exam when relying on disparity to justify surgery at higher acuity levels